MARKET

ADCT

ADCT

Adc Therapeutics Sa
NYSE
1.620
-0.030
-1.82%
Closed 19:53 03/25 EDT
OPEN
1.630
PREV CLOSE
1.650
HIGH
1.670
LOW
1.580
VOLUME
168.89K
TURNOVER
0
52 WEEK HIGH
5.38
52 WEEK LOW
1.390
MARKET CAP
156.64M
P/E (TTM)
-0.6752
1D
5D
1M
3M
1Y
5Y
1D
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
PR Newswire · 11h ago
ADC Therapeutics: Promise Remains, But Fortunes Rest On Success Of Single Trial In 2025
Seeking Alpha · 1d ago
Weekly Report: what happened at ADCT last week (0317-0321)?
Weekly Report · 1d ago
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025
PR Newswire · 5d ago
Weekly Report: what happened at ADCT last week (0310-0314)?
Weekly Report · 03/17 09:03
Does This Valuation Of ADC Therapeutics SA (NYSE:ADCT) Imply Investors Are Overpaying?
Simply Wall St · 03/10 16:50
Weekly Report: what happened at ADCT last week (0303-0307)?
Weekly Report · 03/10 09:03
Cantor Fitzgerald Reiterates Overweight on ADC Therapeuticsto Overweight
Benzinga · 03/07 16:07
More
About ADCT
ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Webull offers ADC Therapeutics SA stock information, including NYSE: ADCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADCT stock methods without spending real money on the virtual paper trading platform.